Literature DB >> 8264862

Secretion of specific nonphosphorylated and phosphorylated rat prolactin isoforms at different stages of the estrous cycle.

T W Ho1, F S Leong, C H Olaso, A M Walker.   

Abstract

The biological activity and immunoreactivity of serum prolactin (PRL) has been shown to fluctuate throughout the estrous cycle of the rat. Since the 24-kDa nonphosphorylated and phosphorylated isoforms from several species have also been shown to differ in their biological and immunoreactivities, we have investigated the possibility that the 24-kDa monomer isoform profile varied throughout the estrous cycle of the rat. The PRL isoform profile was assessed in homogenates of pituitaries and in short-term incubation media. Comparisons between homogenates, which always contained isoforms 1, 2, 3, and 3' (numbered according to increasing acidity), and media showed nonproportional release of the isoforms at all stages. Of great interest were the release of isoform 1 (a nonphosphorylated form) only at estrus and the lack of release of isoform 3' (a phosphorylated form) only in the afternoon of proestrus. This lack of release of 3' was accompanied by a marked increase in the release of isoform 2 (the unmodified polypeptide). These results suggest a unique function for isoform 1 during estrus and a role for increased isoform 2 and absent isoform 3' during the proestrus surge of PRL. Moreover, they suggest that fluctuations in the biological activity and immunoreactivity of serum PRL during the estrous cycle could be due, at least in part, to fluctuations in the isoform profile.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264862     DOI: 10.1159/000126528

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  10 in total

Review 1.  Paradigm-shifters: phosphorylated prolactin and short prolactin receptors.

Authors:  KuangTzu Huang; Eric Ueda; YenHao Chen; Ameae M Walker
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

2.  Unmodified prolactin (PRL) promotes PRL secretion and acidophil hypertrophy and is associated with pituitary hyperplasia in female rats.

Authors:  Terence E Johnson; Mayza Vue; Sharyn Brekhus; Amy Khong; Timothy W C Ho; Ameae M Walker
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

3.  Intragranular prolactin phosphorylation and kallikrein cleavage are regulated by zinc and other divalent cations.

Authors:  M Y Lorenson; J W Liu; T Patel; A M Walker
Journal:  Endocrine       Date:  1996-06       Impact factor: 3.633

Review 4.  Prolactin regulation of mammary gland development.

Authors:  Samantha R Oakes; Renee L Rogers; Matthew J Naylor; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

5.  Common and specific effects of the two major forms of prolactin in the rat testis.

Authors:  Valencia L Williams; Ariel DeGuzman; Hong Dang; Mitsumori Kawaminami; Timothy W C Ho; David G Carter; Ameae M Walker
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-10-02       Impact factor: 4.310

Review 6.  S179D prolactin: antagonistic agony!

Authors:  Ameae M Walker
Journal:  Mol Cell Endocrinol       Date:  2007-06-28       Impact factor: 4.102

7.  S179D prolactin diminishes the effects of UV light on epidermal gamma delta T cells.

Authors:  Esther A Guzmán; John L Langowski; Ariel De Guzman; H Konrad Muller; Ameae M Walker; Laurie B Owen
Journal:  Mol Cell Endocrinol       Date:  2007-09-11       Impact factor: 4.102

Review 8.  From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics.

Authors:  Charles V Clevenger; Jiamao Zheng; Elizabeth M Jablonski; Traci L Galbaugh; Feng Fang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

Review 9.  Prolactin receptor antagonists.

Authors:  C B Kuo; D Coss; A M Walker
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

10.  Estrogen induces phosphorylation of prolactin through p21-activated kinase 2 activation in the mouse pituitary gland.

Authors:  Kazunori Morohoshi; Yuichiro Komatani; Toshio Harigaya
Journal:  J Reprod Dev       Date:  2020-09-19       Impact factor: 2.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.